Completed PHASE4 INTERVENTIONAL 2-arm NCT01656096

Renal Sympathetic Denervation in Mild Refractory Hypertension

Renal Sympathetic Denervation in Patients With Mild Refractory Hypertension

Sponsor: University of Leipzig

Interventions Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA) Sham procedure

Updated 5 times since 2017 Last updated: Oct 27, 2016 Started: Jul 31, 2012 Primary completion: Jul 31, 2014 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Refractory Hypertension and is currently completed. University of Leipzig leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Leipzig

Data source: University of Leipzig

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leipzig, Germany